| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Site Promotion > The Niche Dwellers of Net Land |
|
Digg It - The Niche Dwellers of Net Land
We all live in our own individual niche, although we seldom think of it that way. When I first began bird-w According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product atching, I became aware of the significance of the niche. A large tree will have a bird catching flies near ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in the top. Perhaps a wood-pecker or a creeper will be finding a meal on the trunk. In the shade underneath th lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e boughs, the ground feeders will be scratching out their survival. That big tree could be a metaphor for here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe he Internet, couldn’t it? A quick search of Google, for any term you can think of, will turn up a host of n d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro iche dwellers, all seeming to thrive, in the lush environment of the Internet. When we think about our fri ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc nds, work-mates, neighbors, we realize they are all niche dwellers. I can’t confirm this thesis by any reli easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi able research, but I suspect that this tendency to seek out our own niche may have been made necessary by t nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically e Industrial Revolution, which began many moons ago. As society progresses and our lives become more comple and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ x, finding our own niche to exploit has become a requisite for survival. It seems that the acknowledgment ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi f the niche is a comparatively recent thing, in Internet terms. But as we can see, the concept has been aro ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a und for a long time. "There is nothing new under the sun," Solomon is said to have observed. And that proli dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ic inventor, Thomas Edison, once stated something to the effect that an invention does not have to be total cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ly new, merely the application of it, to a new area. Could this be a fertile field for us to explore? Ther tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen are those who advocate merely finding a concept which has proven successful in the past and adapt it to pr t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel esent day technology. I suspect this may not be a great breakthrough in creative thinking. With only a litt ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e diligence, I feel sure that many examples of this procedure can be found. The most promising place to loo y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products k may be those concepts which are proving successful today. As additional specialties continue to be forged . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de daily, we can become the new niche dwellers of the information age. Could it be that a new, exciting and pr elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ofitable niche may be waiting for you? Remember Solomon’s observation, "There is nothing new under the sun. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Customer Service for Chambers of Commerce Shopping Carts For The Faint Of Heart Yahoo's Overture Gone For Good? Here's What To Do About It
|